The renewal application represents years 35 - 40 of the institutional training grant in pulmonary diseases from the University of Colorado Denver. The continuing goal of the program, is to prepare l /ID and PhD trainees for careers in the translational research of lung diseases. The program incorporates a multidisciplinary and interdisciplinary approach highlighting opportunities for either clinical-translational or basic translational T32 trainees. This is accomplished by recruiting exceptional and committed applicants and exposing them to an environment which features dedicated, experienced, and well funded mentors. To adapt to the current research environment and to facilitate cross fertilization, collaboration and the incorporation of new high throughput platforms we have reorganized the research activity into four firms: Injury, Repair, Remodeling;Vascular Biology;Host Defense, Immunology;and Epithelial Cell Biology. The program plan for both MD and PhD trainees includes oversight by the PD/PI, a programmatic research oversight committee, individual trainee research committees, and trainee mentor(s) in the School of Public Health and the Clinical Science Program of the CTSA. There are also postgraduate degree programs for clinical-translational research trainees (MPH, PhD) and advanced course work for basic translational researchers. The trainees are made aware of their responsibilities when accepting a T32 position, including timelines for accomplishments, and the expectation for application for further fellowship or advanced career development awards. Significant new resources have been obtained for the pulmonary research environment at both the University of Colorado Denver and its affiliated institute. National Jewish Health. The proposed research training is three years, four positions each in post graduate years 5, 6, 7. We maintain our goal of preparing the next generation of pulmonary investigators.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007085-38
Application #
8293155
Study Section
NHLBI Institutional Training Mechanism Review Committee (NITM)
Program Officer
Colombini-Hatch, Sandra
Project Start
1975-07-01
Project End
2015-06-30
Budget Start
2012-07-01
Budget End
2013-06-30
Support Year
38
Fiscal Year
2012
Total Cost
$846,271
Indirect Cost
$58,687
Name
University of Colorado Denver
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Honda, Jennifer R; Connick, Elizabeth; MaWhinney, Samantha et al. (2014) Plasma LL-37 correlates with vitamin D and is reduced in human immunodeficiency virus-1 infected individuals not receiving antiretroviral therapy. J Med Microbiol 63:997-1003
Mathai, Susan K; Schwartz, David A; Warg, Laura A (2014) Genetic susceptibility and pulmonary fibrosis. Curr Opin Pulm Med 20:429-35
Yunt, Zulma X; Mohning, Michael P; Barthel, Lea et al. (2014) Kinetics of the angiogenic response in lung endothelium following acute inflammatory injury with bleomycin. Exp Lung Res 40:415-25
Clark, Brendan J; Jones, Jacqueline; Cook, Paul et al. (2013) Facilitators and barriers to initiating change in medical intensive care unit survivors with alcohol use disorders: a qualitative study. J Crit Care 28:849-56
Macht, Madison; Robinson, Jeffrey C; Graham, Brian B (2013) Updated approach for the assessment of ventilator-associated pneumonia. Crit Care Med 41:2641-2
Ghosh, Moumita; Helm, Karen M; Smith, Russell W et al. (2011) A single cell functions as a tissue-specific stem cell and the in vitro niche-forming cell. Am J Respir Cell Mol Biol 45:459-69
McGhan, Ryan; Radcliff, Tiffany; Fish, Ron et al. (2007) Predictors of rehospitalization and death after a severe exacerbation of COPD. Chest 132:1748-55
Soond, Surinder M; Terry, Jennifer L; Riches, David W H (2006) TRUSS, a tumor necrosis factor receptor-1-interacting protein, activates c-Jun NH(2)-terminal kinase and transcription factor AP-1. FEBS Lett 580:4591-6
Portnoy, Joshua; Pan, Tianli; Dinarello, Charles A et al. (2006) Alveolar type II cells inhibit fibroblast proliferation: role of IL-1alpha. Am J Physiol Lung Cell Mol Physiol 290:L307-16
O'Brien Jr, James M; Welsh, Carolyn H; Fish, Ronald H et al. (2004) Excess body weight is not independently associated with outcome in mechanically ventilated patients with acute lung injury. Ann Intern Med 140:338-45

Showing the most recent 10 out of 60 publications